Alcon Inc.
Bosch 69
PO Box 62
Hunenberg,
6331
Switzerland - Map
Phone: 41 41 785 88 88
Fax: 41 41 785 88 87
Web Site: http://www.alconinc.com
| Alcon, Inc. engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally. The company offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. Its ophthalmic surgical products consist of surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. The companys consumer eye care products include contact lens care products, such as disinfecting solutions, cleaners, and lens rewetting drops; vision care products, including artificial tears to treat dry eye syndrome and ocular vitamins, as well as dietary supplements, such as Age Related Eye Disease Study Formula, Lutein, and Zeaxanthin formula. Alcon sells its pharmaceutical products to physicians, distributors, wholesalers, hospitals, government agencies, and large retailers; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and consumer eye care products directly to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It has collaboration with River Plate Biotechnology, Inc. and AstraZeneca plc; and research and licensing agreement with PhiloGene Inc. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestle S.A. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Kevin J. Buehler , 51
Chief Exec. Officer, Pres |
$
960.00K |
$
2.35M | Mr. Richard J. Croarkin , 54
Chief Financial Officer, Sr. VP of Fin. and Corp. Strategy Officer |
$
720.00K |
$
0 | Dr. Elaine E. Whitbeck , 54
Chief Legal Officer, Sr. VP, Corp. Sec. and Gen. Counsel |
$
792.00K |
$
0 | Dr. Sabri Markabi M.D., 50
Chief Medical Officer and Sr. VP of R&D |
$
380.00K |
$
0 | Mr. Ed McGough , 48
Sr. VP of Global Manufacturing & Technical Operations |
$
570.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.34% Nasdaq 
0.22 (0.15%) 
Profile
